Aarhus University Seal / Aarhus Universitets segl

Esben Thyssen Vestergaard

Acute Peripheral Metabolic Effects of Intraarterial Leg Infusion of Somatostatin in Healthy Young Men

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • The Department of Endocrinology and Metabolism C
  • The Department of Endocrinology and Diabetes
  • The Department of Paediatrics
  • Department of Pharmacology
  • Medical Research Laboratory
Context: Evidence suggests that somatostatin not only inhibits the secretion of GH but also suppresses GH action in peripheral tissues. Objective: We tested the hypothesis that somatostatin suppresses GH activity in human skeletal muscle in vivo. Design and Participants: Eight healthy young men (25.3 ± 2.8 yr) were studied on a single occasion after an overnight fast for 4 h [including a basal period (0-2 h) and a hyperinsulinemic euglycemic clamp (2-4 h)] during an iv GH infusion (50 ng/kg(-1)·min(-1)). Each subject received an intraarterial somatostatin infusion (150 μg/h(-1)) into one femoral artery and an intraarterial saline infusion into the contra lateral artery. The simultaneous blood samples were drawn from both femoral veins. Muscle biopsies were obtained from one leg at t = 0 and from both legs during the basal period and during the clamp. Main Outcome Measures: Muscle glucose uptake, signaling proteins for GH (phosphorylated signal transducer and activator of transcription-5) and insulin (phosphorylation of AS160), and expression of GH-regulated genes (IGF-I and suppressor of cytokine signaling 1-3) were measured. Results: Somatostatin significantly increased glucose uptake measured by arteriovenous glucose difference during the basal period (P = 0.03) but not during the clamp. There was a tendency for the phosphorylation of AS160 to be higher in the somatostatin-infused leg compared with the saline leg (P = 0.055). The expression of suppressor of cytokine signaling-1 mRNA was significantly elevated in the clamp-biopsy from the saline-infused leg (P = 0.024). Conclusions: We concluded the following: 1) in the presence of systemic GH exposure, somatostatin increases basal glucose uptake and reduces the expression of GH-regulated genes directly in skeletal muscle; 2) this supports the concept that somatostatin suppresses GH activity in peripheral tissues, and 3) this may add to the therapeutic effects of somataostatin analogs.
Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
ISSN0021-972X
DOIs
Publication statusPublished - 1 Jun 2011

See relations at Aarhus University Citationformats

ID: 37661496